Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Vitamin D, calcitriol prodrug; VDR agonist.
PORCN inhibitor.
Found in Schisandra.
SERM.
Mycotoxin contaminant found in cereal grains.
Tetracycline; protein translation inhibitor, MM...
β-adrenergic antagonist, Kv1.4 and K2P2 K+ cha...
PDE and adenosine deaminase inhibitor.
Peptide hormone, neurotensin analog found in am...
AChE inhibitor, F0F1-ATP synthase modulator.
STAT3 inhibitor.
Kavalactone originally found in Piper methystic...
β-lactam; penicillin binding protein inhibitor...
Downregulates LPS-stimulated expression of pro-...
Oxazolidone derivative; Factor Xa inhibitor.
EGFR inhibitor.
Adenosine analog
Tetrapeptide, IgG Fc region derivative; Nrp1 ag...
DHF reductase inhibitor.